American Stroke Association Meeting Report
- Feb 6, 2019
- 1 min read
Target: Stroke program demonstrates substantially improved outcomes in adherence to stroke care guidelines; phase III kicks off
American Stroke Association Meeting Report: POSTER SESSION I - Poster Board Number LBP9 / Presentation Number LBP9
Highlights:
There was substantial further improvement in time to alteplase administration in GWTG-Stroke hospitals after implementation of Target: Stroke Phase II achieving door-to-needle times within 60 minutes for 75 percent or more of acute ischemic stroke patients.
Target: Stroke Phase II was associated with improvements in clinical outcomes for patients with acute ischemic stroke.
Target: Stroke Phase III launches with national goal to achieve door-to-needle times within 60 minutes for 85 percent or more patients and achieve to door-to-device times within 90 minutes for direct arriving patients and within 60 minutes for transfer patients in 50 percent or more patients treated with endovascular therapy
Comments